Rankings
▼
Calendar
MLTX Q2 2021 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$33M
Net Income
-$33M
EPS (Diluted)
$-0.89
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$6,140
Free Cash Flow
$6,140
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$116M
Total Liabilities
$4M
Stockholders' Equity
$112M
Cash & Equivalents
$1M
← FY 2021
All Quarters
Q3 2021 →
